Stay updated on Secukinumab Long-term Efficacy in PsA Clinical Trial
Sign up to get notified when there's something new on the Secukinumab Long-term Efficacy in PsA Clinical Trial page.

Latest updates to the Secukinumab Long-term Efficacy in PsA Clinical Trial page
- ChecktodayChange DetectedRevision: v3.5.5 appears, replacing the previous v3.5.4, indicating a new page version. This update is a metadata version change rather than a substantive edit to study details or results.SummaryDifference0.0%

- Check7 days agoChange DetectedNo changes were provided to analyze in the <website_changes> data for this page.SummaryDifference0.0%

- Check14 days agoChange DetectedDocumented changes are absent; the page content has not been modified. The study record continues to reflect the extension study details for secukinumab in psoriatic arthritis.SummaryDifference0.0%

- Check22 days agoChange DetectedA new site revision tag 'v3.5.4' was added, replacing 'v3.5.3', indicating a software release update; no trial content or data on the page is changed.SummaryDifference0.0%

- Check43 days agoChange DetectedUpdated the ClinicalTrials.gov page footer to reflect a new site/application revision version (v3.5.3 instead of v3.5.2).SummaryDifference0.0%

- Check50 days agoChange DetectedRevision updated from v3.5.0 to v3.5.2 on the page.SummaryDifference0.0%

Stay in the know with updates to Secukinumab Long-term Efficacy in PsA Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Secukinumab Long-term Efficacy in PsA Clinical Trial page.